Literature DB >> 12065501

Inhibition of leukocyte rolling by nitric oxide during sepsis leads to reduced migration of active microbicidal neutrophils.

Claudia Farias Benjamim1, João Santana Silva, Zuleica Bruno Fortes, Maria Aparecida Oliveira, Sérgio Henrique Ferreira, Fernando Queiroz Cunha.   

Abstract

We developed two models of sepsis with different degrees of severity, sublethal and lethal sepsis, induced by cecal ligation and puncture. Lethal sepsis induced by cecal ligation and puncture (L-CLP) resulted in failure of neutrophil migration to the infection site and high mortality. Treatment of septic animals with aminoguanidine (AG), a nitric oxide (NO) synthase inhibitor, precluded the failure of neutrophil migration and protected the animals from death. However, cytokine-induced NO synthase (iNOS)-deficient (iNOS(-/-)) mice subjected to L-CLP did not present neutrophil migration failure, but 100% lethality occurred. iNOS(-/-) mice subjected to sublethal sepsis induced by cecal ligation and puncture (SL-CLP) also suffered high mortality despite the occurrence of neutrophil migration. This apparent paradox could be explained by the lack of microbicidal activity in neutrophils of iNOS(-/-) mice present at the infection site due to their inability to produce NO. Notably, SL- and L-CLP iNOS(-/-) mice showed high bacterial numbers in exudates. The inhibition of neutrophil migration by NO is due to inhibition of a neutrophil/endothelium adhesion mechanism, since a reduction in leukocyte rolling, adhesion, and emigration was observed in L-CLP wild-type mice. These responses were prevented by AG treatment and were not observed in the iNOS(-/-) L-CLP group. There was no significant change in L-selectin expression in neutrophils from L-CLP mice. Thus, it seems that the decrease in leukocyte rolling is due to a defect in the expression of adhesion molecules on endothelial surfaces mediated by iNOS-derived NO. In conclusion, the results indicate that despite the importance of NO in neutrophil microbicidal activity, its generation in severe sepsis reduces neutrophil migration by inhibiting leukocyte rolling and their firm adhesion to the endothelium, in effect impairing the migration of leukocytes and consequently their fundamental role in host cell defense mechanisms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065501      PMCID: PMC128083          DOI: 10.1128/IAI.70.7.3602-3610.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

Review 1.  Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention.

Authors:  J Panés; M Perry; D N Granger
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

2.  Interleukin-10: the ambiguity in sepsis continues.

Authors:  P E Parsons
Journal:  Crit Care Med       Date:  1998-05       Impact factor: 7.598

3.  Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation.

Authors:  M Ellis; S Gupta; S Galant; S Hakim; C VandeVen; C Toy; M S Cairo
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

4.  Increased microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide synthase.

Authors:  S M Hollenberg; M Broussard; J Osman; J E Parrillo
Journal:  Circ Res       Date:  2000-04-14       Impact factor: 17.367

5.  The intravenous administration of tumor necrosis factor alpha, interleukin 8 and macrophage-derived neutrophil chemotactic factor inhibits neutrophil migration by stimulating nitric oxide production.

Authors:  B M Tavares-Murta; F Q Cunha; S H Ferreira
Journal:  Br J Pharmacol       Date:  1998-08       Impact factor: 8.739

6.  Nitric Oxide in Arthritis

Authors: 
Journal:  Methods       Date:  1996-08       Impact factor: 3.608

Review 7.  Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS)

Authors:  R C Bone
Journal:  Ann Intern Med       Date:  1996-10-15       Impact factor: 25.391

8.  Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation.

Authors:  R T Gazzinelli; I Eltoum; T A Wynn; A Sher
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

9.  Inhibition of leukocyte chemotaxis by factor in alloxan-induced diabetic rat plasma.

Authors:  M A Pereira; P Sannomiya; J G Leme
Journal:  Diabetes       Date:  1987-11       Impact factor: 9.461

10.  Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis.

Authors:  G J Bagby; K J Plessala; L A Wilson; J J Thompson; S Nelson
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226

View more
  36 in total

1.  Septic mice are susceptible to pulmonary aspergillosis.

Authors:  Claudia F Benjamim; Cory M Hogaboam; Nicholas W Lukacs; Steven L Kunkel
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

2.  Sildenafil prevents indomethacin-induced gastropathy in rats: role of leukocyte adherence and gastric blood flow.

Authors:  Camila L Santos; Marcellus H L P Souza; Antoniella S Gomes; Henrique P Lemos; Armênio A Santos; Fernando Q Cunha; John L Wallace
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

Review 3.  Therapeutic potential and limitations of cholinergic anti-inflammatory pathway in sepsis.

Authors:  Alexandre Kanashiro; Fabiane Sônego; Raphael G Ferreira; Fernanda V S Castanheira; Caio A Leite; Vanessa F Borges; Daniele C Nascimento; David F Cólon; José Carlos Alves-Filho; Luis Ulloa; Fernando Q Cunha
Journal:  Pharmacol Res       Date:  2016-12-12       Impact factor: 7.658

4.  Cytotoxicity against tumor cell lines and anti-inflammatory properties of chitinases from Calotropis procera latex.

Authors:  Carolina Araújo Viana; Márcio V Ramos; José Delano Barreto Marinho Filho; Letícia Veras Costa Lotufo; Ingrid Samantha Tavares Figueiredo; Jefferson Soares de Oliveira; Pietro Mastroeni; José Vitor Lima-Filho; Nylane Maria Nunes Alencar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-07-11       Impact factor: 3.000

5.  PPAR-γ/IL-10 axis inhibits MyD88 expression and ameliorates murine polymicrobial sepsis.

Authors:  Ana Elisa Ferreira; Flavia Sisti; Fabiane Sônego; Suojuan Wang; Luciano Ribeiro Filgueiras; Stephanie Brandt; Ana Paula Moreira Serezani; Hong Du; Fernando Q Cunha; Jose Carlos Alves-Filho; Carlos Henrique Serezani
Journal:  J Immunol       Date:  2014-01-31       Impact factor: 5.422

6.  Activation of AMPK enhances neutrophil chemotaxis and bacterial killing.

Authors:  Dae Won Park; Shaoning Jiang; Jean-Marc Tadie; William S Stigler; Yong Gao; Jessy Deshane; Edward Abraham; Jaroslaw W Zmijewski
Journal:  Mol Med       Date:  2013-11-08       Impact factor: 6.354

7.  Gastric damage and granulocyte infiltration induced by indomethacin in tumour necrosis factor receptor 1 (TNF-R1) or inducible nitric oxide synthase (iNOS) deficient mice.

Authors:  M H L P Souza; H Paula Lemos; R B Oliveira; F Q Cunha
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

8.  A protein C deficiency exacerbates inflammatory and hypotensive responses in mice during polymicrobial sepsis in a cecal ligation and puncture model.

Authors:  Jorge G Ganopolsky; Francis J Castellino
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

9.  Involvement of NO in the failure of neutrophil migration in sepsis induced by Staphylococcus aureus.

Authors:  D P Crosara-Alberto; A L C Darini; R Y Inoue; J S Silva; S H Ferreira; F Q Cunha
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

10.  Peroxynitrite mediates the failure of neutrophil migration in severe polymicrobial sepsis in mice.

Authors:  D Torres-Dueñas; M R N Celes; A Freitas; J C Alves-Filho; F Spiller; D Dal-Secco; V F Dalto; M A Rossi; S H Ferreira; F Q Cunha
Journal:  Br J Pharmacol       Date:  2007-07-16       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.